Park and Hwang found that serum levels of S100 calcium-binding protein β (S100-β) and neuron-specific enolase (NSE) in patients with brain injuries were associated with initial Glasgow Coma Scale (GCS) scores and clinical outcomes. The gene discussed is ENO2; the disease is brain injury.